Literature DB >> 1721287

The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.

A Francavilla1, T E Starzl, B Carr, A Azzarone, G Carrieri, Q H Zeng, K A Porter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721287      PMCID: PMC2994247     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

1.  FK 506 as a growth control factor.

Authors:  A Francavilla; M Barone; T E Starzl; A Zeevi; C Scotti; G Carrieri; V Mazzaferro; J Prelich; S Todo; G Eiras
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

3.  Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.

Authors:  A Francavilla; T E Starzl; M Barone; Q H Zeng; K A Porter; A Zeevi; P M Markus; M R van den Brink; S Todo
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

4.  Cyclosporine A augments the regenerative response after partial hepatectomy in the rat.

Authors:  D Kahn; H S Lai; H Romovacek; L Makowka; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats.

Authors:  Y I Kim; R Y Calne; N Nagasue
Journal:  Surg Gynecol Obstet       Date:  1988-04

6.  Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.

Authors:  A Francavilla; M Barone; S Todo; Q Zeng; K A Porter; T E Starzl
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

7.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors:  J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

8.  A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.

Authors:  M W Harding; A Galat; D E Uehling; S L Schreiber
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

9.  The hepatotropic influence of cyclosporine.

Authors:  V Mazzaferro; K A Porter; C L Scotti-Foglieni; R Venkataramanan; L Makowka; L Rossaro; A Francavilla; S Todo; D H Van Thiel; T E Starzl
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

10.  Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Authors:  T E Starzl; K Watanabe; K A Porter; C W Putnam
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

View more
  6 in total

Review 1.  Hepatic regeneration and growth factors.

Authors:  A Francavilla; L Polimeno; M Barone; A Azzarone; T E Starzl
Journal:  J Surg Oncol Suppl       Date:  1993

2.  Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration.

Authors:  A Francavilla; Q Zeng; L Polimeno; B I Carr; D Sun; K A Porter; D H Van Thiel; T E Starzl
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

Review 3.  New immunosuppressive drugs: mechanistic insights and potential therapeutic advances.

Authors:  A W Thomson; T E Starzl
Journal:  Immunol Rev       Date:  1993-12       Impact factor: 12.988

Review 4.  Exploiting novel molecular targets in gastrointestinal cancers.

Authors:  Wen W Ma; Manuel Hidalgo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

5.  Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells.

Authors:  L Polimeno; A Azzarone; Q H Zeng; C Panella; V Subbotin; B Carr; B Bouzahzah; A Francavilla; T E Starzl
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

Review 6.  The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis.

Authors:  D J Hele; M H Yacoub; M G Belvisi
Journal:  Respir Res       Date:  2001-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.